BioMérieux Gets CE Mark for Three Dengue Immunoassays
The three tests run on the firm's Vidas systems and expand the firm's footprint in vector-borne disease.
Startup CRISPR Firm Caspr Biotech Developing COVID Dx Using New Extremophile Bacteria Nuclease
Caspr's assay can be transported at room temperature and performed without complex external equipment, making it ideal for low-resource environments.
Kephera Diagnostics Wins $2M SBIR Grant From NIAID to Develop Zika Virus Antibody Test
The test is aimed at detecting Zika antibodies in a highly specific way that avoids cross-reactivity with the dengue virus, according to the firm.
Broad Institute Researchers Develop Viral Detection Platform Based on Microfluidics, CRISPR Tech
The platform can detect a single virus in more than 1,000 samples at a time or more than 160 viruses, including SARS-CoV-2, in a small number of samples.
The method detects dengue virus from blood serum or plasma using DNA nanostructures and aptamers and can potentially be read with a portable fluoroscope.